PFAS exposure is linked to five documented health effects: kidney and testicular cancer, thyroid disease, high cholesterol, reduced vaccine response, and pregnancy complications. The EPA's 2024 risk assessment and decades of peer-reviewed research confirm these associations, though exact dose-response relationships vary by compound.
We know more about PFAS health effects than almost any other emerging contaminant class. Not because the chemicals are new (they've been manufactured since the 1940s), but because one lawsuit forced chemical companies to fund the largest community health study ever conducted on an industrial pollutant.
That study – the C8 Science Panel – followed 69,000 people in West Virginia and Ohio exposed to PFOA-contaminated drinking water from a DuPont plant. Between 2005 and 2013, the panel published findings linking PFOA exposure to six specific health outcomes. The EPA's 2024 IRIS assessment, IARC's cancer classifications, and the National Academies' 2022 PFAS report all build on that foundation.
But here's what makes this complicated: we're not talking about one chemical. PFAS is a class of over 12,000 compounds. The bulk of human health research focuses on just two – PFOA and PFOS – because those were the dominant compounds in drinking water when researchers started looking. Newer PFAS like GenX and PFBS are largely understudied.
These are the associations with the strongest evidence base, ranked by consistency across studies:
Three other effects have emerging evidence but less consensus: liver damage (improved enzymes), ulcerative colitis, and developmental delays in children. The research here is early. Take it seriously, but don't treat it as settled.
Regulators don't agree on everything, but the core findings overlap:
| Health Effect | EPA 2024 Classification | IARC Classification | Strength of Evidence | |---------------|------------------------|---------------------|---------------------| | Kidney cancer (PFOA) | Likely carcinogenic | Group 1 (carcinogenic) | Strong – multiple cohorts | | Testicular cancer (PFOA) | Likely carcinogenic | Group 1 (carcinogenic) | Strong – C8 + occupational studies | | High cholesterol | Associated | Not classified | Very strong – consistent across populations | | Reduced vaccine response | Associated | Not classified | Strong – National Academies: sufficient evidence | | Thyroid disease | Associated | Not classified | Moderate – inconsistent dose-response | | Liver effects (enzyme changes) | Suggestive | Not classified | Weak – animal data stronger than human |
According to the EPA's 2024 Integrated Risk Information System (IRIS) assessment, PFOA and PFOS both meet the criteria for "likely to be carcinogenic to humans." IARC went further in 2023, upgrading PFOA to Group 1 – the same category as asbestos and tobacco. The difference comes down to how each agency weighs mechanistic evidence (how the chemical causes cancer at the cellular level) versus epidemiological evidence (what we see in exposed populations).
The C8 Science Panel found that people in the highest exposure quartile had double the risk of kidney cancer and 2.8 times the risk of testicular cancer compared to the lowest quartile. Those findings held up even after controlling for smoking, obesity, and family history.
But context matters here. Testicular cancer is rare – about 6 cases per 100,000 men per year in the U.S. A 2.8-fold increase brings that to roughly 17 per 100,000. That's not nothing, but it's not the 20-fold increases you see with, say, smoking and lung cancer. And the C8 study looked at people drinking water with PFOA levels between 0.3 and 3.2 parts per billion – significantly higher than the EPA's new legal limit of 4 parts per trillion for PFOA.
According to Vieira et al. (2013), the kidney cancer association appears strongest in people over age 60 with more than 10 years of improved exposure. Shorter exposures or exposures starting later in life show weaker associations. So time and dose both matter.
We're less sure about other cancer types. Some studies link PFAS to breast, prostate, and liver cancers, but the findings are inconsistent. The National Academies reviewed the evidence in 2022 and concluded there wasn't enough data to draw firm conclusions beyond kidney and testicular cancer.
Almost every PFAS cohort study reports thyroid effects – usually hypothyroidism (underactive thyroid) or improved TSH levels. According to the National Health and Nutrition Examination Survey (NHANES) data analyzed by Melzer et al. each 1 ng/mL increase in serum PFOA was associated with a 1.38-fold increase in thyroid disease prevalence.
But the mechanism is murky. PFAS molecules structurally resemble thyroid hormones, which has led researchers to hypothesize that they interfere with hormone transport or receptor binding. Animal studies support this – rats exposed to PFOS show thyroid hormone disruption at relatively low doses. Yet when researchers look at dose-response curves in humans, the relationship isn't always linear. Some studies show effects at low doses that disappear at higher doses, which doesn't fit standard toxicology models.
Our take: the association is real, but we don't yet understand the pathway well enough to predict who's most at risk. If you have PFAS in your drinking water and a family history of thyroid disease, that's worth discussing with your doctor.
In 2022, the National Academies of Sciences, Engineering, and Medicine released a 400-page evaluation of PFAS health effects. Of all the outcomes they reviewed, they assigned the highest confidence level – "sufficient evidence of an association" – to reduced antibody response to vaccines in children.
The key study here is Grandjean et al. (2012), which followed children in the Faroe Islands exposed to PFAS through seafood and found that those with higher serum PFOS and PFOA levels had significantly lower antibody concentrations after routine childhood vaccinations (diphtheria, tetanus). A separate study by Granum et al. in Norway found similar results.
This matters because it's one of the few PFAS health effects observable at exposure levels common in the general U.S. population – not just in highly contaminated communities. According to CDC biomonitoring data, most Americans have detectable PFAS in their blood. The vaccine studies suggest that even low-level, widespread exposure may have immune consequences.
We're not sure yet whether reduced vaccine response translates to higher infection rates in real-world settings. The studies measured antibody titers, not disease outcomes. But it's a plausible pathway, and it's one of the reasons the EPA tightened drinking water limits in 2024.
If there's one health effect that shows up in every PFAS study, it's improved cholesterol. The C8 Science Panel found it. NHANES found it. Occupational studies of chemical plant workers found it. Even studies of low-level environmental exposure find modest increases in LDL cholesterol associated with PFAS.
According to Steenland et al. (2009), each 1 ng/mL increase in serum PFOA was associated with a 0.66 mg/dL increase in total cholesterol. That's small on an individual level – not enough to move someone from normal to high cholesterol on its own. But at a population level, even small shifts in cholesterol distributions can translate to measurable increases in cardiovascular disease.
The mechanism is likely tied to PFAS disruption of lipid metabolism in the liver. Animal studies show that PFAS activate peroxisome proliferator-activated receptors (PPARs), which regulate fat storage and cholesterol synthesis. Frankly, the cholesterol link is strong enough that it should be part of any cardiovascular risk discussion for people with documented PFAS exposure.
The research gaps are large. We know almost nothing about:
The National Academies acknowledged this uncertainty and recommended expanded biomonitoring and long-term cohort studies. That work is happening, but results take years.
You can't eliminate PFAS exposure entirely – they're too widespread. But you can reduce it:
And if you live near a military base, airport, or industrial site where firefighting foam was used, get your well water tested. Those are the highest-exposure scenarios we see in the U.S. and they're the situations where filtration or an alternative water source makes the biggest difference.
PFAS health effects are real, documented, and backed by decades of research. The evidence is strongest for cancer (kidney and testicular), immune suppression, cholesterol, thyroid disease, and pregnancy complications. We're less certain about liver damage, developmental delays, and newer PFAS compounds – the research is ongoing.
But here's the hard truth: even with all this data, individual risk is tough to predict. Not everyone exposed to PFAS develops cancer or thyroid disease. Genetics, co-exposures (other contaminants in your water or environment), and baseline health all matter. PFAS is one variable in a complex system.
What we can say with confidence is that reducing exposure – especially for vulnerable populations like pregnant women and young children – is worth doing. The science supports it, and the tools to do it (filtration, product swaps, awareness) are accessible.
What are the main health effects of PFAS exposure? The five most documented PFAS health effects are high cholesterol, reduced vaccine response in children, thyroid disease, kidney and testicular cancer, and pregnancy complications including low birth weight and preeclampsia. These associations are supported by the C8 Science Panel, EPA, IARC, and peer-reviewed cohort studies.
Does PFAS cause cancer? Yes. IARC classified PFOA as a Group 1 carcinogen (carcinogenic to humans) in 2023 based on evidence linking it to kidney and testicular cancer. The C8 Science Panel found that highly exposed individuals had 2-3 times the risk of these cancers compared to low-exposure groups. Other cancer types have weaker evidence.
At what level does PFAS become dangerous? There's no established "safe" threshold for most PFAS health effects. The EPA's 2024 drinking water limits (4 parts per trillion for PFOA and PFOS) are based on cancer and developmental toxicity risk modeling, but some effects like immune suppression appear at lower levels common in the general population.
Can PFAS affect children differently than adults? Yes. Children show stronger immune system effects – specifically reduced antibody response to vaccines. Developmental effects and thyroid disruption also appear more pronounced in early life. The National Academies found sufficient evidence to recommend prioritizing PFAS exposure reduction for pregnant women and young children.
How long does PFAS stay in your body? PFOA and PFOS have elimination half-lives of 2-4 years in humans, meaning it takes years for your body to clear half of the accumulated amount. Newer short-chain PFAS like PFBS have shorter half-lives (weeks to months), but we have less data on their health effects. Reducing ongoing exposure is the only way to lower body burden over time.